The FDA has approved first-time generic formulations for alprazolam 0.5-mg extended-release tablets (Xanax XR); cabergoline 0.5-mg tablets (Dostinex); and oxycodone HCl-acetaminophen 2.5-300-mg, 5-300-mg, 7.5-300-mg, and 10-300-mg tablets (Percocet).
Medscape Medical NewsYael Waknine
Click Here to read the entire article...